Inflammatory breast cancer: early recognition and diagnosis is critical
Authors:
- 1 October 2021
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 225 (4) , 392-396
Abstract
No abstract availableKeywords
Funding Information
- Merck
- Breast Cancer Research Foundation
- Genentech
This publication has 18 references indexed in Scilit:
- Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed TherapyAmerican Journal of Clinical Oncology, 2015
- Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosisBreast Cancer Research and Treatment, 2015
- Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer DatabaseJournal of Clinical Oncology, 2014
- Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohortThe Lancet Oncology, 2014
- Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancerCancer, 2014
- Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypesAnnals of Oncology, 2013
- International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatmentAnnals of Oncology, 2010
- Locoregional Treatment Outcomes After Multimodality Management of Inflammatory Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Trends in Inflammatory Breast Carcinoma Incidence and Survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer InstituteJNCI: Journal of the National Cancer Institute, 2005
- Long-Term Follow-Up for Locally Advanced and Inflammatory Breast Cancer Patients Treated With Multimodality TherapyJournal of Clinical Oncology, 2004